Institut de Recerca Biomèdica de Lleida clinical trials
Institut de Recerca Biomèdica de Lleida is the lead sponsor of 4 current clinical trials in our Spain register. 2 are recruiting patients now. The most common phase is Observational. The most-studied condition is Metabolic Syndrome.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Institut de Recerca Biomèdica de Lleida
4 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Genetic Susceptibility to Predict Weight Loss After Bariatric Surgery
NCT06226194 · ClinicalTrials.gov ↗ · Bariatric Surgery Candidate, Obesity, Morbid, Genetic Predisposition
|
Observational | Recruiting | 2024-03 | Spain |
|
Comprehensive Maintenance Program: a Health Haven for COPD in Lleida.The NAPOLEON Project.
NCT07394712 · ClinicalTrials.gov ↗ · COPD - Chronic Obstructive Pulmonary Disease, Pulmonary Rehabilitation, Randomised Controlled Trial
|
Not applicable | Recruiting | 2025-10 | Spain |
|
Longitudinal Recovery Trajectories After an Acute Respiratory Distress Syndrome, a New Understanding
NCT06083363 · ClinicalTrials.gov ↗ · ARDS, ARDS Disease Progression
|
Observational | Active, closed | 2023-06 | Spain |
|
The ILERVAS Project: Assessing the Prevalence of Subclinical Vascular Disease and Hidden Kidney Disease
NCT03228459 · ClinicalTrials.gov ↗ · Atherosclerosis, Chronic Kidney Diseases, Metabolic Syndrome
|
Not applicable | Active, closed | 2015-01 | Spain |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Conditions in Institut de Recerca Biomèdica de Lleida trials
12 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Spain | 4 | 2 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Metabolic Syndrome
| Sponsor | Trials |
|---|---|
| Laval University | 4 |
| University of Erlangen-Nürnberg Medical School | 2 |
| University of Seville | 2 |
| University of Guadalajara | 2 |
| Industrial Farmacéutica Cantabria | 1 |
| Universidad Pública de Navarra | 1 |
Sponsors with the most current trials registered for this condition.
Questions about Institut de Recerca Biomèdica de Lleida trials
How many clinical trials does Institut de Recerca Biomèdica de Lleida sponsor?
Institut de Recerca Biomèdica de Lleida is the lead sponsor of 4 current trials on ClinicalTrials.gov in our Spain register, as of the registry sync on 14 November 2026. Completed and withdrawn studies are not counted.
Are Institut de Recerca Biomèdica de Lleida trials recruiting?
Yes. 2 of its 4 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 14 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.